期刊文献+

中药通心络(超微粉碎)对猪急性心肌梗死再灌注后无再流的影响 被引量:33

Effect of Tongxinluo Ultramicro-pulverization on Myocardial Post-reperfusion No-reflow in Mini-Swine Model of Acute Myocardial Infarction
下载PDF
导出
摘要 目的评价通心络(超微粉碎)防治猪急性心肌梗死(AMI)再灌注后无再流的作用。方法中华小型猪40只随机分为对照组,小剂量(0·05g/kg·d)、中剂量(0·2g/kg·d)、大剂量(0·5g/kg·d)通心络(超微粉碎)组和假手术组,每组8只。治疗组预给药3天后行冠状动脉结扎3h,松解1h制备AMI再灌注模型。AMI前后和再灌注后均行血流动力学测定和心肌声学造影(MCE)检查,最终行病理学分析。结果与对照组比较,小、中和大剂量通心络(超微粉碎)可改善再灌注后的心功能,分别减少无再流面积由对照组的(78·5±4·4)%和(82·3±1·9)%至(43·4±3·2)%和(44·6±3·3)%,(25·2±2·4)%和(25·7±4·0)%,(24·0±1·9)%和(24·9±4·2)%(P<0·05或P<0·01),分别减少心肌梗死面积由对照组的(98·5±1·4)%至(89·8±4·6)%,(80·2±3·1)%和(79·9±3·1)%(P<0·05或P<0·01)。结论通心络(超微粉碎)能有效地防治心肌梗死再灌注后无再流,缩小梗死面积。 Objective To assess the effect of Tongxinluo (TXL) ultramicro-pulverization in preventing and treating post-reperfusion no-reflow in mini-swine model of acute myocardial infarction. Methods Forty mini- swines were randomly divided into 5 groups, the control group, the three (low-, middle- and high-dose) TXL groups and the sham-operation group, with 8 in each group. After pigs in the three TXL groups were administered with TXL in a dose of 0.05g/kg, 0.2g/kg and 0.Sg/kg once a day for 3 days respectively, they were made into acute myocardial ischemia/reperfusion model by ligating left anterior descending coronary artery for 3h followed with lh of untying. Hemodynamic examination and myocardial contrast echocardiography (MCE) were conducted before and after ligation, and after reperfusion, finally, pathological analysis was done. Results Post-reperfusion ventricular function injury was significantly improved in the three TXL groups, as compared with the control group, the no-reflow area determined by hemodynamic and MCE decreased from 78.5± 4.4 % and 82.3 ± 1.9% in control to 43.4± 3.2% and 44.6 ± 3.3% (low-dose), 25.2 ± 2.4% and 25.7 ± 4.0% (middle-dose), 24.0± 1.9% and 24.9_±4.2% (high-dose), respectively (P〈0.05 or P〈0.01), and the myocardial infracted area was reduced from 98.5 ± 1.4 % to 89.8 ± 4.6 %, 80.2 ± 3.1% and 79.9 ± 3.1%, respectively (P〈 0.05, P 〈 0.01). Conclusion TXL ultramicro-pulverization can effectively prevent and treat no-reflow after myocardial acute infarction following reperfusion, and reduce the infracted area.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2006年第1期49-53,共5页 Chinese Journal of Integrated Traditional and Western Medicine
基金 国家自然科学基金资助项目(No.90209038)
关键词 通心络 超微粉碎 无再流 急性心肌梗死 心肌声学造影 中药 Tongxinluo Ultramicro-Pulverization no-reflow acute myocardial ischemia swine myocardial contrast echocardiography
  • 相关文献

参考文献13

  • 1Ito H,Maruyama A,Iwakura K,et al.Clinical implications of the ‘no-reflow' phenomenon:a predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction.Circulation 1996; 93:223-228.
  • 2Gersh BJ.Optimal management of acute myocardial infarction at the down of the next millennium.Am Heart J 1999; 138 (2Pt2):188-202.
  • 3Piana RN,Paik GY,Moscucci M,et al.Incidence and treat ment of "no-reflow" after percutaneous coronary intervention.1994;89:2514.
  • 4Ito H,Tomooka T,Sakai N,et al.Lack of myocardial perfusion immediately after successful thrombolysis:a predictor of poor recovery of left ventricular function in anterior myocardial infarction.Circulation 1992; 85:1699-1705.
  • 5Abbo KM,Dooris M,Glaziar S.Features and outcome of noreflow after percutaneous coronary intervention.Am J Cardiol 1995 ;75:778-82.
  • 6Morshima J.Long term prognostic impact of angiographic noreflow phenomenon in patients treated with angioplasty for acute myocardial infarction possible involvement of left ventricular remodeling.Circulation 1999; 100(Suppl 1):451-456.
  • 7韩会萍,张秀荣.通心络胶囊对不稳定型心绞痛患者内皮功能的影响[J].现代中西医结合杂志,2004,13(3):307-307. 被引量:22
  • 8文丹,张金早,柯红,吴发明.黄芪注射液治疗糖尿病肾病临床观察[J].中国中医急症,2004,13(6):369-370. 被引量:37
  • 9肖文良,戴华,姜志安,张晓光,赵书健,耿小勇,邰炜彦.通心络胶囊对不稳定性心绞痛患者血管内皮细胞保护作用的研究[J].中华心血管病杂志,2002,30(5):268-268. 被引量:92
  • 10Eeckhout E,Kern MJ.The coronary no-reflow phenomenon:a review of mechanism and therapies.Eur Heart J 2001; 22:729-739.

二级参考文献21

  • 1李丽英,于宏,潘缉圣,王海燕.黄芪与当归对肾病综合征患者总体蛋白质代谢的影响[J].中华内科杂志,1995,34(10):670-672. 被引量:83
  • 2[2]Mehta JL. Endothelium coronary vasodilation and organic nitrates[J]. AmHeart J,1995,129:382-391
  • 3[3]Anderson TJ,Uehata A,Gerhard MD,et al. Close relation of endothelial function in the human coronary and peripheral circulations[J]. J Am Coll Cardiol,1995,26:1235-1241
  • 4[4]Anderson TJ,Gerhard MD,Meredith IT,et al. Systemicnature of endothelial dysfunction in atherosclerosis[J]. Am J Cardiol,1995,75:71-74
  • 5[6]MasaKi T. Molecular and celluer mechanism of endothelin regulation implications for vascular function[J]. Circuiation,1991,84:1457-1461
  • 6林朝胜 佟铭 赵凯.冠心病心绞痛发作与循环内皮素水平关系的探讨[J].实用内科学杂志,1994,14(12):742-742.
  • 7Mogesen CE, Christensen CK. The diabetic kidney from hyperfihration and microalbumin to end- stage renal failure[J].Med Clin Nor Am, 1988, 72(9): 1465
  • 8.中药新药临床研究指导原则(第1辑)[S].[S].中华人民共和国卫生部,1993.41-45.
  • 9KlonerRA,PrzyklenkK.CardiovascRes,1993,27:162-166.
  • 10WrzotkowalT,etal.UltrastucturalstudiesonthevitaminDinducedheartlesionsintherat.J.MolCellCardiol,1980,12(10):1117.

共引文献187

同被引文献434

引证文献33

二级引证文献247

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部